サルコペニア治療市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲治療タイプ別（ビタミンDとカルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメント、その他）、流通チャネル別（薬局、小売チャネル、オンラインチャネル、その他）、地域別（北米、欧州、アジア太平洋、中東＆アフリカ、南米＆中米）

Sarcopenia Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Vitamin D and Calcium Supplements, Protein Supplements, Vitamin B12 Supplements, and Others), Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

弊社の最新調査レポート「サルコペニア治療市場の2030年までの予測-世界分析-治療タイプ、流通チャネル」によると、サルコペニア治療市場規模は2022年の33億9,700万米ドルから2030年には52億6,400万米ドルに達す... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年12月1日	US$5,190 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	134	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

弊社の最新調査レポート「サルコペニア治療市場の2030年までの予測-世界分析-治療タイプ、流通チャネル」によると、サルコペニア治療市場規模は2022年の33億9,700万米ドルから2030年には52億6,400万米ドルに達すると予測されています。当レポートでは、市場の動向やサルコペニア治療市場の成長を促進・阻害する要因について明らかにしています。

サルコペニアとその健康への悪影響に対する認識の高まりは、ヘルスケアと老人介護の分野における進歩の大きな可能性を示している。多くの擁護団体や組織は、大衆のサルコペニアに対する認識を高めるために積極的な対策を講じている。これらの団体はしばしば医療専門家と協力し、迅速な診断と治療の価値を強調するとともに、病原性、対象患者、予防、治療などの様々な側面について一般大衆に最新情報を提供している。米国保健福祉省女性健康局（OWH）は2023年、女性のサルコペニアに対する認識を拡大するため、全国キャンペーン「Stronger than Sarcopenia（サルコペニアより強く）」を開始した。保健福祉省の調査によると、米国では高齢者の45％以上がサルコペニアを患っており、数百万人の若年層が人生の後半にこの症状を発症する危険性がある。OWHの "Stronger than Sarcopenia"（サルコペニアより強く）キャンペーンに沿い、女性は医療提供者とサルコペニアについて話し合い、病気の検査を受け、必要であれば適切な治療を受けるよう強く求められている。

サルコペニアは、医学部のカリキュラムや、医師、看護師、理学療法士などの医療専門家のトレーニング・プログラムにも取り入れられている。例えば、OWHはMedscape Educationと協力し、医療専門家のための継続的医学教育（CME）クレジットを作成した。主要メディアは、記事、ニュース、ドキュメンタリーなど、サルコペニアの報道を拡大している。2022年2月のPubMedの記事によると、米国保健福祉省は、サルコペニアに関する1,604件の研究を後援している、米国でもトップクラスの資金提供機関である。2022年からは、7月4日が「世界サルコペニア・デー」となる。このように、サルコペニアに関する意識の高まりは、今後数年間、サルコペニア治療市場に新たな成長トレンドをもたらす可能性が高い。

サルコペニア治療市場は、治療タイプ別にビタミンD・カルシウムサプリメント、プロテインサプリメント、ビタミンB12サプリメント、その他に区分される。2022年には、ビタミンD・カルシウムサプリメント分野が最大シェアを占めた。このセグメントのサルコペニア治療市場は、2022年から2030年にかけて最も高いCAGR 6.5%を記録すると予測されている。脂溶性ビタミンであるビタミンDは、カルシウムのホメオスタシスと健康な骨代謝の維持に不可欠である。ビタミンDの補給は、サルコペニアのリスクを軽減する有用な食事戦略として研究されてきた。ビタミンD濃度が十分でない高齢者はサルコペニアに罹患しやすく、しばしば転倒、入院、その他の悪影響を伴う。
カナダ公衆衛生局、米国保健福祉省、NIHは、サルコペニア治療市場に関する報告書作成中に参照したいくつかの主要な一次および二次情報源である。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Sarcopenia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Sarcopenia Treatment Market – Key Industry Dynamics
5.1 Sarcopenia Treatment Market – Key Industry Dynamics
5.2 Market Drivers
5.2.1 Upsurge in Geriatric Population
5.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
5.3 Key Market Restraints:
5.3.1 Unavailability of Direct Interventions
5.4 Key Market Opportunities:
5.4.1 Products in Clinical Trial Phases
5.5 Future Trends:
5.5.1 Rising Awareness About Sarcopenia
5.6 Impact of Drivers and Restraints:
6. Sarcopenia Treatment Market – Global Market Analysis
6.1 Sarcopenia Treatment Market Revenue (US$ Million), 2022 – 2030
6.2 Sarcopenia Treatment Market Forecast and Analysis
7. Sarcopenia Treatment Market Analysis – By Treatment Type
7.1 Vitamin D and Calcium Supplement
7.1.1 Overview
7.1.2 Vitamin D and Calcium Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Protein Supplement
7.2.1 Overview
7.2.2 Protein Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Vitamin B12 Supplement
7.3.1 Overview
7.3.2 Vitamin B12 Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. Sarcopenia Treatment Market Analysis – By Distribution Channel
8.1 Pharmacies
8.1.1 Overview
8.1.2 Pharmacies Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Retail Channels
8.2.1 Overview
8.2.2 Retail Channels Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Online Channels
8.3.1 Overview
8.3.2 Online Channels Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Sarcopenia Treatment Market – Geographical Analysis
9.1 Overview
9.2 North America
9.2.1 North America Sarcopenia Treatment Market Overview
9.2.2 North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.2.3 North America Sarcopenia Treatment Market Breakdown by Treatment Type
9.2.3.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Treatment Type
9.2.4 North America Sarcopenia Treatment Market Breakdown by Distribution Channel
9.2.4.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Distribution Channel
9.2.5 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.2.5.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.2.5.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.2.5.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
9.2.5.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
9.2.5.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.2.5.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
9.2.5.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
9.2.5.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.2.5.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
9.2.5.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3 Europe
9.3.1 Europe Sarcopenia Treatment Market Overview
9.3.2 Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.3 Europe Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.3.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Treatment Type
9.3.4 Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.4.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Distribution Channel
9.3.5 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.3.5.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.3.5.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.5.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.5.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.5.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.5.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3.5.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.3.5.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
9.3.5.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4 Asia Pacific
9.4.1 Asia Pacific Sarcopenia Treatment Market Overview
9.4.2 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.3 Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.3.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Treatment Type
9.4.4 Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.4.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Distribution Channel
9.4.5 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.4.5.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.4.5.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.5.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.5.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.5.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.5.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4.5.7 Rest of APAC Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.4.5.7.1 Rest of APAC Sarcopenia Treatment Market Breakdown by Treatment Type
9.4.5.7.2 Rest of APAC Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5 Middle East and Africa
9.5.1 Middle East and Africa Sarcopenia Treatment Market Overview
9.5.2 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.5.3 Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
9.5.3.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Treatment Type
9.5.4 Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5.4.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Distribution Channel
9.5.5 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.5.5.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.5.5.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.5.5.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
9.5.5.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5.5.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.5.5.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
9.5.5.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5.5.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.5.5.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
9.5.5.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5.5.5 Rest of Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.5.5.5.1 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
9.5.5.5.2 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9.6 South and Central America
9.6.1 South and Central America Sarcopenia Treatment Market Overview
9.6.2 South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.6.3 South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
9.6.3.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Treatment Type
9.6.4 South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
9.6.4.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Distribution Channel
9.6.5 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.6.5.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
9.6.5.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.6.5.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
9.6.5.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
9.6.5.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.6.5.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
9.6.5.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
9.6.5.4 Rest of South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.6.5.4.1 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
9.6.5.4.2 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
10. Sarcopenia Treatment Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Sarcopenia Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Bayer AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Metagenics LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Nestle Health Science SA
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Sanofi SA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Amway Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GSK Plc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Makers Nutrition LLC
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

According to our latest study on "Sarcopenia Treatment Market Forecast to 2030 – Global Analysis – Treatment Type, and Distribution Channel," the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women's Health (OWH) of the US Department of Health and Human Services launched the national campaign "Stronger than Sarcopenia" in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.
The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?